Status not kept up to date
Robot Mediated Therapy-Feasibility Study and Preliminary Effects
NCT05729633 · Changi General Hospital · Updated 15 Feb 2023
- What is being tested
- Robot mediated upper limb therapy
- For
- Stroke
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 21 years to 99 years. About 4 people. The full rules are on the registry page.
- Where
- Not stated
- When
- Starts or started Feb 2023, ends July 2023. Registered 15 Feb 2023.
- Results
- None posted yet.
In the researchers' words
The goal of this clinical trial is to investigate the feasibility of the application of robot mediated impairment-training (RMIT) and robot mediated task-specific training (RMTT) in acute stroke patients with upper limb impairments. The main question\[s\] it aims to answer are: * Is it feasible and safe to conduct RMIT and RMTT in acute stroke patients with upper limb impairments? * What are the preliminary effects on the physical function and quality of life in these patients? Participants will undergo 20 hours of robot mediated upper limb therapy. Researchers will compare RMIT with RMIT+RMTT to see if there are any differences in the effects on physical function and quality of life.